Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

What Physiomics (LSE:PYC) Reports on Mechanistic Mathematical Modeling for Novel Immuno-Oncology Candidates

Physiomics plc (LSE:PYC) continues to demonstrate operational progress in computational oncology, entering strategic collaborations and deploying its proprietary mathematical modeling software to optimize preclinical and clinical drug development for global biopharmaceutical clients. Quoted on the AIM market of the London Stock Exchange, the computational …

Divya Sood | 15 October 2026

Why Genus (LSE:GNS) Shares Have Lagged the FTSE 250 Despite a 35% Jump in Annual Profit

Genus, the FTSE 250 animal genetics company behind the PIC pig and ABS cattle breeding businesses, finds itself in an unusual position this autumn. Its full-year results, published on 10 September, showed profits rising sharply and debt falling sharply. Yet the shares fell by …

Ankur Sharma | 15 October 2026

EDX Medical Group PLC (LSE:EDX): Can Diagnostic Launches Become a Scalable Business?

EDX Medical Group PLC (LSE:EDX) is being assessed against the latest company-specific information available as at 15 October 2026.

Ankur Sharma | 15 October 2026

Genedrive plc (LSE:GDR): What Could Put the Shares in Focus Next?

Genedrive plc is a healthcare-sector stock listed on AIM and included in the broader FTSE AIM All-Share market context.

Ankur Sharma | 15 October 2026

ImmuPharma plc (LSE:IMM): What Could Put the Shares in Focus Next?

ImmuPharma plc is a healthcare-sector stock listed on AIM and included in the broader FTSE AIM All-Share market context.

Ankur Sharma | 15 October 2026

IXICO PLC (LSE:IXI): Neuroscience Imaging Growth Raises the Bar for Revenue Conversion

IXICO PLC (LSE:IXI) is being assessed against the latest company-specific information available as at 15 October 2026.

Ankur Sharma | 15 October 2026

Oxford BioDynamics plc (LSE:OBD): What Could Put the Shares in Focus Next?

Oxford BioDynamics plc is a healthcare-sector stock listed on AIM and included in the broader FTSE AIM All-Share market context.

Ankur Sharma | 15 October 2026

Proteome Sciences plc (LSE:PRM): What Could Put the Shares in Focus Next?

Proteome Sciences plc is a healthcare-sector stock listed on AIM and included in the broader FTSE AIM All-Share market context.

Ankur Sharma | 15 October 2026

ValiRx PLC (LSE:VAL): Biotechnology Pipeline Progress Must Be Matched by Funding Discipline

ValiRx PLC (LSE:VAL) is being assessed against the latest company-specific information available as at 15 October 2026.

Ankur Sharma | 15 October 2026

Arecor Therapeutics PLC (LSE:AREC): Why This AIM Stock Is in Focus on 15 October 2026 and What Comes Next

Arecor Therapeutics PLC (LSE:AREC) is assessed against its operating exposure to innovative insulin formulations. The relevant investor questions concern patent protection, partners and funding.

Ankur Sharma | 15 October 2026
Support

Hi! How can we help you today?

Loading…